Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

17.59USD
10:17pm IST
Change (% chg)

$-0.14 (-0.82%)
Prev Close
$17.74
Open
$17.74
Day's High
$17.74
Day's Low
$17.28
Volume
5,709
Avg. Vol
19,158
52-wk High
$38.48
52-wk Low
$16.26

Carter, Martha 

Ms. Martha J. Carter is the Chief Regulatory Officer of Albireo Pharma Inc, since November 2016. Ms. Carter has served as our Chief Regulatory Officer since November 2016. She previously served as Chief Regulatory Officer and Senior Vice President of Aegerion Pharmaceuticals, Inc. (a publicly held biopharmaceutical company) from February 2011 to July 2016. From January 2011 to February 2011, Ms. Carter served as Senior Vice President and Chief Regulatory Officer at Proteon Therapeutics, Inc. (a privately held biopharmaceutical company), and from September 2006 to December 2010, she served as Senior Vice President, Regulatory Affairs and Quality Assurance, at Proteon. From September 2002 to April 2006, Ms. Carter was Senior Vice President, Regulatory Affairs, for Trine Pharmaceuticals. Prior to joining Trine, Ms. Carter was Vice President, Regulatory Affairs for GelTex Pharmaceuticals, Inc. and served in regulatory affairs roles at Genetics Institute, ImmuLogic Pharmaceutical Corporation and Serono Laboratories. Ms. Carter holds a B.A. from Northeastern University.

Basic Compensation

Total Annual Compensation, USD 388,872
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 854,603
Fiscal Year Total, USD 1,243,480

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018